Informazioni sul prodotto
- (4aR,6aS,7aR,10aR,11aR,11bR,11cR)-1,2,3,4,4a,5,6,11a,11b,11c-Decahydro-4,4,8,11c-tetramethylbisoxireno[1,10a:3,4]phenanthro[3,2-b]furan-9(7aH)-one
- Bisoxireno[1,10a:3,4]phenanthro[3,2-b]furan-9(7aH)-one, 1,2,3,4,4a,5,6,11a,11b,11c-decahydro-4,4,8,11c-tetramethyl-, (4aR,6aS,7aR,10aR,11aR,11bR,11cR)-
- Bisoxireno[1,10a:3,4]phenanthro[3,2-b]furan-9(7aH)-one, 1,2,3,4,4a,5,6,11a,11b,11c-decahydro-4,4,8,11c-tetramethyl-, [4aR-(4aα,6aS*,7aβ,10aR*,11aβ,11bα,11cβ)]-
- bisoxireno[3,4:1,10a]phenanthro[3,2-b]furan-9(7aH)-one, 1,2,3,4,4a,5,6,11a,11b,11c-decahydro-4,4,8,11c-tetramethyl-, (4aR,6aS,7aR,10aR,11aR,11bR,11cR)-
Jolkinolide B is a natural compound that has exhibited potent cytotoxicity against HL-60 cells and significant cytotoxicity against K562 cells. In addition, Jolkinolide B also exhibits apoptotic effects in HL-60 cells. The mechanism by which Jolkinolide B induces apoptosis may be due to the induction of reactive oxygen species, activation of caspases, or interference with mitochondrial membrane potential. This natural compound is a potent inducer of the cell signaling pathways MMP and JNK. In addition, Jolkinolide B also exhibits strong inhibitory activity against the proliferation of MCF-7 cancer cells, which are estrogen receptor-positive breast cancer cells.
Proprietà chimiche
Richiesta tecnica su: 3D-MBA90508 Jolkinolide B
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
